| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1999;100:559-563.)
© 1999 American Heart Association, Inc.
Current Perspective |
Ischemic Preconditioning in Humans
Models, Mediators, and Clinical Relevance
From the Divisione di Cardiochirurgia, Università di Roma Tor Vergata, European Hospital and Istituto di Cardiologia (F.C.), Università Cattolica del Sacro Cuore, Rome, Italy.
Correspondence to Dr Fabrizio Tomai, Divisione di Cardiochirurgia, Università di Roma Tor Vergata, European Hospital, via Portuense 700, 00149 Rome, Italy.
Abstract—Ischemic
preconditioning, a powerful form of endogenous protection
against myocardial infarction, has been demonstrated in several animal
species and, recently, in isolated human cardiomyocytes.
For both logistic and ethical reasons, no clinical study can meet the
strict conditions of experimental studies on preconditioning with
infarct size as the end-point. Nevertheless, the demonstration of
adaptation to ischemia observed during in vitro studies on
human atrial trabeculae, in patients in the setting of
coronary bypass surgery, and in the setting of coronary
angioplasty in the absence of collateral vessel recruitment strongly
suggests that ischemic preconditioning occurs in humans. This
notion is further supported by the observation that in these human
models, the adaptation to ischemia is influenced by drugs
acting on KATP channels and on purinergic and
-adrenergic receptors, similar to what is observed in accepted
experimental models of ischemic preconditioning. This important
form of myocardial endogenous protection may also play a
role in the warm-up phenomenon and in mediating the beneficial effects
of preinfarction angina. The demonstration of ischemic
preconditioning in humans and the identification of some of its
mediators suggests that in patients at high risk for myocardial
infarction, drugs known to block this endogenous form of
protection should be used with caution, whereas drugs known to elicit
preconditioning might have a relevant therapeutic role.
Key Words: angina • ischemia • myocardial infarction
This article has been cited by other articles:
 |
|
 |
|
  G. S. Murphy, J. W. Szokol, J. H. Marymont, S. B. Greenberg, M. J. Avram, J. S. Vender, S. S. Sherwani, M. Nisman, and V. Doroski Morphine-Based Cardiac Anesthesia Provides Superior Early Recovery Compared with Fentanyl in Elective Cardiac Surgery Patients Anesth. Analg., August 1, 2009; 109(2): 311 - 319. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. Velly, P. T. Canas, B. A. Guillet, C. N. Labrande, F. M. Masmejean, A. L. Nieoullon, F. M. Gouin, N. J. Bruder, and P. S. Pisano Early Anesthetic Preconditioning in Mixed Cortical Neuronal-Glial Cell Cultures Subjected to Oxygen-Glucose Deprivation: The Role of Adenosine Triphosphate Dependent Potassium Channels and Reactive Oxygen Species in Sevoflurane-Induced Neuroprotection Anesth. Analg., March 1, 2009; 108(3): 955 - 963. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. G. Katare, M. Ando, Y. Kakinuma, M. Arikawa, T. Handa, F. Yamasaki, and T. Sato Vagal nerve stimulation prevents reperfusion injury through inhibition of opening of mitochondrial permeability transition pore independent of the bradycardiac effect. J. Thorac. Cardiovasc. Surg., January 1, 2009; 137(1): 223 - 231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Crea, P. G. Camici, R. De Caterina, and G. A. Lanza CHAPTER 17 Chronic Ischaemic Heart Disease ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Wang, N. Oka, M. Tropak, J. Callahan, J. Lee, G. Wilson, A. Redington, and C. A. Caldarone Remote ischemic preconditioning elaborates a transferable blood-borne effector that protects mitochondrial structure and function and preserves myocardial performance after neonatal cardioplegic arrest. J. Thorac. Cardiovasc. Surg., August 1, 2008; 136(2): 335 - 342. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Niccoli, L. Altamura, A. Fabretti, G. A. Lanza, L. M. Biasucci, A. G. Rebuzzi, A. M. Leone, I. Porto, F. Burzotta, C. Trani, et al. Ethanol Abolishes Ischemic Preconditioning in Humans J. Am. Coll. Cardiol., January 22, 2008; 51(3): 271 - 275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Zhong and D. H. Wang TRPV1 gene knockout impairs preconditioning protection against myocardial injury in isolated perfused hearts in mice Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1791 - H1798. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Spear, S. K. Prabu, D. Galati, H. Raza, H. K. Anandatheerthavarada, and N. G. Avadhani beta1-Adrenoreceptor activation contributes to ischemia-reperfusion damage as well as playing a role in ischemic preconditioning Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2459 - H2466. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gheorghiade, G. Sopko, L. De Luca, E. J. Velazquez, J. D. Parker, P. F. Binkley, Z. Sadowski, K. S. Golba, D. L. Prior, J. L. Rouleau, et al. Navigating the Crossroads of Coronary Artery Disease and Heart Failure Circulation, September 12, 2006; 114(11): 1202 - 1213. [Full Text] [PDF]
|
|
|
|
|
|
N. P. Riksen, Z. Zhou, W. J.G. Oyen, R. Jaspers, B. P. Ramakers, R. M.H.J. Brouwer, O. C. Boerman, N. Steinmetz, P. Smits, and G. A. Rongen Caffeine Prevents Protection in Two Human Models of Ischemic Preconditioning J. Am. Coll. Cardiol., August 15, 2006; 48(4): 700 - 707. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Korom, S. Hillinger, M. Cardell, W. Zhai, Q. Tan, A. Dutly, B. Leskosek, and W. Weder Sildenafil extends survival and graft function in a large animal lung transplantation model Eur. J. Cardiothorac. Surg., March 1, 2006; 29(3): 288 - 293. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Prabu, H. K. Anandatheerthavarada, H. Raza, S. Srinivasan, J. F. Spear, and N. G. Avadhani Protein Kinase A-mediated Phosphorylation Modulates Cytochrome c Oxidase Function and Augments Hypoxia and Myocardial Ischemia-related Injury J. Biol. Chem., January 27, 2006; 281(4): 2061 - 2070. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Domenech Preconditioning: A New Concept About the Benefit of Exercise Circulation, January 3, 2006; 113(1): e1 - e3. [Full Text] [PDF]
|
|
|
|
 |
|
 I. Ungi, T. Ungi, Z. Ruzsa, E. Nagy, Z. Zimmermann, T. Csont, and P. Ferdinandy Hypercholesterolemia Attenuates the Anti-ischemic Effect of Preconditioning During Coronary Angioplasty Chest, September 1, 2005; 128(3): 1623 - 1628. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Penna, G. Alloatti, S. Cappello, D. Gattullo, G. Berta, B. Mognetti, G. Losano, and P. Pagliaro Platelet-activating factor induces cardioprotection in isolated rat heart akin to ischemic preconditioning: role of phosphoinositide 3-kinase and protein kinase C activation Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2512 - H2520. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Liem, M. te Lintel Hekkert, O. C. Manintveld, F. Boomsma, P. D. Verdouw, and D. J. Duncker Myocardium tolerant to an adenosine-dependent ischemic preconditioning stimulus can still be protected by stimuli that employ alternative signaling pathways Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1165 - H1172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Gori, S. Sicuro, S. Dragoni, G. Donati, S. Forconi, and J. D. Parker Sildenafil Prevents Endothelial Dysfunction Induced by Ischemia and Reperfusion via Opening of Adenosine Triphosphate-Sensitive Potassium Channels: A Human In Vivo Study Circulation, February 15, 2005; 111(6): 742 - 746. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Garcia, K. Julier, L. Bestmann, A. Zollinger, L. K. von Segesser, T. Pasch, D. R. Spahn, and M. Zaugg Preconditioning with sevoflurane decreases PECAM-1 expression and improves one-year cardiovascular outcome in coronary artery bypass graft surgery Br. J. Anaesth., February 1, 2005; 94(2): 159 - 165. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. Rongen, W. J.G. Oyen, B. P. Ramakers, N. P. Riksen, O. C. Boerman, N. Steinmetz, and P. Smits Annexin A5 Scintigraphy of Forearm as a Novel In Vivo Model of Skeletal Muscle Preconditioning in Humans Circulation, January 18, 2005; 111(2): 173 - 178. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Barthel, D. Ebel, J. Mullenheim, D. Obal, B. Preckel, and W. Schlack Effect of lidocaine on ischaemic preconditioning in isolated rat heart Br. J. Anaesth., November 1, 2004; 93(5): 698 - 704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Waldow, K. Alexiou, W. Witt, F. M. Wagner, V. Gulielmos, K. Matschke, and M. Knaut Attenuation of Reperfusion-Induced Systemic Inflammation by Preconditioning With Nitric Oxide in an In Situ Porcine Model of Normothermic Lung Ischemia Chest, June 1, 2004; 125(6): 2253 - 2259. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Arboix, M. Tarruella, L. Garcia-Eroles, M. Oliveres, C. Miquel, M. Balcells, and C. Targa Ischemic stroke in patients with intermittent claudication: a clinical study of 142 cases Vascular Medicine, February 1, 2004; 9(1): 13 - 17. [Abstract] [PDF]
|
|
|
|
 |
|
 D. M. YELLON and J. M. DOWNEY Preconditioning the Myocardium: From Cellular Physiology to Clinical Cardiology Physiol Rev, October 1, 2003; 83(4): 1113 - 1151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Miura Myocardial response to ischemic preconditioning: is it a novel predictor of prognosis? J. Am. Coll. Cardiol., September 17, 2003; 42(6): 1004 - 1006. [Full Text] [PDF]
|
|
|
|
|
|
M. A. Leesar, M. F. Stoddard, Y.-T. Xuan, X.-L. Tang, and R. Bolli Nonelectrocardiographic evidence that both ischemic preconditioning and adenosine preconditioning exist in humans J. Am. Coll. Cardiol., August 6, 2003; 42(3): 437 - 445. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Bartling, I. Friedrich, R.-E. Silber, and A. Simm Ischemic preconditioning is not cardioprotective in senescent human myocardium Ann. Thorac. Surg., July 1, 2003; 76(1): 105 - 111. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. D. Lambiase, R. J. Edwards, M. R. Cusack, C. A. Bucknall, S. R. Redwood, and M. S. Marber Exercise-induced ischemia initiates the second window of protection in humans independent of collateral recruitment J. Am. Coll. Cardiol., April 2, 2003; 41(7): 1174 - 1182. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Weinbrenner, M. Nelles, N. Herzog, L. Sarvary, and R. H Strasser Remote preconditioning by infrarenal occlusion of the aorta protects the heart from infarction: a newly identified non-neuronal but PKC-dependent pathway Cardiovasc Res, August 15, 2002; 55(3): 590 - 601. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Smith Jr, D. Faxon, W. Cascio, H. Schaff, T. Gardner, A. Jacobs, S. Nissen, and R. Stouffer Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group VI: Revascularization in Diabetic Patients Circulation, May 7, 2002; 105 (18): e165 - e169. [Full Text] [PDF]
|
|
|
|
 |
|
 F Tomai Warm up phenomenon and preconditioning in clinical practice Heart, February 1, 2002; 87(2): 99 - 100. [Full Text] [PDF]
|
|
|
|
|
|
P. J. Gheeraert, J. P. S. Henriques, M. L. De Buyzere, M. De Pauw, Y. Taeymans, and F. Zijlstra Preinfarction angina protects against out-of-hospital ventricular fibrillation in patients with acute occlusion of the left coronary artery J. Am. Coll. Cardiol., November 1, 2001; 38(5): 1369 - 1374. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. D. Raeburn, J. C. Cleveland Jr, M. A. Zimmerman, and A. H. Harken Organ Preconditioning Arch Surg, November 1, 2001; 136(11): 1263 - 1266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Leesar, M. F. Stoddard, B. Dawn, V. G. Jasti, R. Masden, and R. Bolli Delayed Preconditioning-Mimetic Action of Nitroglycerin in Patients Undergoing Coronary Angioplasty Circulation, June 19, 2001; 103(24): 2935 - 2941. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Nandagopal, T. M. Dawson, and V. L. Dawson Critical Role for Nitric Oxide Signaling in Cardiac and Neuronal Ischemic Preconditioning and Tolerance J. Pharmacol. Exp. Ther., April 12, 2001; 297(2): 474 - 478. [Abstract] [Full Text]
|
|
|
|
|
|
S. Salvi Protecting the Myocardium From Ischemic Injury : A Critical Role for {{alpha}}1-Adrenoreceptors? Chest, April 1, 2001; 119(4): 1242 - 1249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-C. COPIN, Y. GASCHE, Y. LI, and P. H. CHAN Prolonged hypoxia during cell development protects mature manganese superoxide dismutase-deficient astrocytes from damage by oxidative stress FASEB J, February 1, 2001; 15(2): 525 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Lu, H. Otani, T. Yamamura, Y. Nakao, R. Hattori, H. Ninomiya, M. Osako, and H. Imamura Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia J. Thorac. Cardiovasc. Surg., January 1, 2001; 121(1): 0137 - 148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M Mohan and D. J Paterson Activation of sulphonylurea-sensitive channels and the NO-cGMP pathway decreases the heart rate response to sympathetic nerve stimulation Cardiovasc Res, July 1, 2000; 47(1): 81 - 89. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-C. Wellner-Kienitz, K. Bender, T. Meyer, M. Bunemann, and L. Pott Overexpressed A1 Adenosine Receptors Reduce Activation of Acetylcholine-Sensitive K+ Current by Native Muscarinic M2 Receptors in Rat Atrial Myocytes Circ. Res., March 31, 2000; 86(6): 643 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gonzalez-Zulueta, A. B. Feldman, L. J. Klesse, R. G. Kalb, J. F. Dillman, L. F. Parada, T. M. Dawson, and V. L. Dawson Requirement for nitric oxide activation of p21ras/extracellular regulated kinase in neuronal ischemic preconditioning PNAS, January 4, 2000; 97(1): 436 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Birincioglu, X.-M. Yang, S. D. Critz, M. V. Cohen, and J. M. Downey S-T segment voltage during sequential coronary occlusions is an unreliable marker of preconditioning Am J Physiol Heart Circ Physiol, December 1, 1999; 277(6): H2435 - H2441. [Abstract] [Full Text] [PDF]
|
|